Biotech Index Jumps As No News From Democratic Debate Is Good NewsMark Melin
When a former "shady" hedge fund manager, who has now been called the most hated man in America, Martin Shkreli punched prices higher on a life-saving drug by over 5,000 percent, it caused an uproar in Washington D.C., drawing the ire of U.S. presidential candidate Hillary Clinton on Twitter. A prevailing thought was . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.